Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies 
ICC Judges Sue Trump Administration Over Sanctions, Calling Measures Unlawful 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Russia-Ukraine War: Fresh Strikes Injure Civilians as Fuel Crisis Worsens in Russia 
Russia Signals Frustration Over Unfulfilled U.S. Commitments After Alaska Summit 
Cait Conley Wins Democratic Nomination, Sets Up Key House Battle Against Mike Lawler in New York 
Lebanon Pushes Ahead With Israel Talks Despite Iran-U.S. Deal Impact 
US Mobilizes Aid After Powerful Earthquakes Devastate Venezuela 
U.S. Reviewing Potential F-35 Fighter Jet Sale to Turkey Amid S-400 Dispute 
US Delivers $13M Autonomous Maritime Drones to Philippines 
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response 
US Seeks Gulf Support for Iran Peace Deal Amid Regional Tensions 
Andy Burnham Emerges as Favorite After Keir Starmer Resigns 
Rubio Faces Gulf Skepticism Over U.S.-Iran Peace Deal 
Trump Requests $11 Billion More in Farm Aid as Rising Costs Pressure U.S. Farmers 
Crimea Power Outage After Ukrainian Drone Attack, Russian Authorities Say 
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
